Moderate anticonvulsant action of baclofendoes not change during development

Neonatology

Volumn 69, Issue 6, 1996, Pages 405-412

  Kubová, Hana ^a   Haugvicová, Renata ^a   Mareš, Pavel ^a,b  

^a INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Anticonvulsant action; Baclofen; Pentylenetetrazol; Rat development; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTICONVULSIVE AGENT; BACLOFEN; PENTETRAZOLE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; BACLOFEN; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA AGONISTS; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES;

ANIMALIA;

EID: 0029955377     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244338     Document Type: Article

References (41)

1. Bowery NG: GABAn receptor pharmacology, Annu Rev Pharmacol Toxicol ¡993:33:109-147.
2. Sandyk R, Bamford CR: Baclofen responsive posttraumatic epilepsy, Int JNeurosci 1987;37:183-185.
3. Kotier M, Arturo-Lcis A: Prolonged seizure activity after baclofen withdrawal, Neurology 1992:42:697-698.
4. May CR: Baclofen overdose, Ann EmcrgMed 1983:12:171-173.
5. Saltuiari L, Marosi MJ, Kofler M, Bauer G: Status epilepticus complicating intrathecal baclofen overdose, Lancet 1992;339:373-374.
6. Amabeoku G: Involvement of GABAergic mechanisms in chloro-quine-induced seizures in mice, Gen Pharmacol 1992:23:225-229.
7. Amabeoku G, Chikumi O: Effects of some GABAergic agents on quinine-induced seizures in mice, Experien-tia 1992;48:659-662.
8. Ault B, Gruenthal M, Armstrong DR, Nadler JV: Efficacy of baclofen against the kainic acid limbic sci-zure-brain damage syndrome, J Pharmacol ExpTher 1986;239:612-617.
9. Lapin IP, Rhyzhov IV: Convulsions induced by kynurenine and quinolinic acid as a sensitive test for assessing the anticonvulsant activity of GABAergic preparations (in Russian), Biull Eksp Biol Med 1983:95: 53-55.
10. Petersen EN: DMCM: A potent convulsive benzodiazepine receptor ligand, Eur J Pharmacol 1983:94: 117-124.
11. Sato K, Morimoto K, Okamoto M, Nakamura Y, Otsuki S, Sato M: An analysis of anticonvulsant action of GABA agonists (progabide and baclofen) in the kindling model of epilepsy, Epilepsy Res 1990:5:117-124.
12. Stringer JL, Lothman EW: Pharmacological evidence indicating a role of GABAergic systems in termination of limbic seizures, Epilepsy Res 1990:7:197-204.
13. Holland KD, McKeon AC, Canney DJ, Covey DF, Ferrendelli JA: Relative anticonvulsant effects of GABA mimetic and GABA modulatory agents, Epilepsia 1993:33:981-986.
14. Mehta AK, Tieku MK: Comparison of anticonvulsant effect of pentobarbital and phcnobarbital against seizures induced by maximal electro-shock and picrotoxin in rats, Pharmacol Biochem Behav 1986:25: 1059-1065.
15. Cottrell GA, Robertson HA: Baclofen exacerbates epileptic myoclonus in kindled rats, Neuropharmacology 1987:26:645-648.
16. Meldrum B: GABAcrgic agents as anticonvulsants in baboons with photosensitive epilepsy, Neurosci Lett 1984:47:345-349.
17. Aley KO, Kulkartii SK: Altered response to GABAergic agents following electro- and chemoconvulsions in mice, Indian J Exp Biol 1991:29: 241-243.
18. Karlsson G, Kolb C, Hausdorf A, Portet C, Schmutz M, Olpe HR: GABAb receptors in various in vitro and in vivo models of epilepsy: A study with the GABAb receptor blocker CGP 35348, Neuroscience 1992:47:63-68.
19. Lin FH, Cao Z, Hosford DA: Increased number of GABAb receptors in lethargic (lh/lh) mouse model of absence epilepsy, Brain Res 1992; 608:101-106.
20. Snead OC III: Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures, Eur J Pharmacol 1992:213:343-349.
21. Hosford DA, Clark S, Cao Z, Wilson WA Jr., Lin FH, Morrisett RA, Huin A: The role of GABAb receptor activation in absence seizures of lethargic (lh/lh) mice, Science 1992:257: 398-401.
22. Vergnes M, Marescaux C, Micheletti G, Dcpaulis A, Rumbach L, War-ter JM: Enhancement of spike-and-wave discharges by GABAcrgic drugs in rats with spontaneous pctit-mal-like epilepsy, Neurosci Lett 1984:44:91-94.
23. Bernasconi R, Laubcr J, Marescaux C, Vergnes M, Martin P, Rubio V, Leonhardt T, Reymann N, Bittigcr H: Experimental absence seizures: Potential role of gamma-aminobu-tyric acid and GABAb receptors, J Neural Transm 1992:35(suppl): 155-177.
24. Marescaux C, Vergnes M, Bernasconi R: GABAb receptor antagonists: Potential new anti-absence drugs, J Neural Transm 1992:35(suppl): 179-188.
25. Wurpcl JN, Sperber EF, Mosto SL: Baclofen inhibits amygdala kindling in immature rats, Epilepsy Res 1990:5:1-7.
26. Moshé SL, Sperber EF, Brown LL, Tempel A: Age-dependent changes in substantia nigra GABA-mediatcd seizure suppression, Epilepsy Res 1992;8(suppl):97-106.
27. Sperber EF, Wurpcl JN, Moshé SL: Evidence for the involvement of nigral GABAb receptors in seizures of rat pups, Brain Res Dev Brain Res 1989:47:143-146.
28. Mares P, Zouhar A: Do we possess adequate models of childhood epilepsies? Physiol Bohemoslov 1988: 37:1-9.
29. Swinyard EA, Woodhead JK, White HS, Franklin MR: Experimental detection, quantification and evaluation of anticonvulsants; in Levy RH, Dreifuss FE, Mattson RH, Meldrunt BS, Pcnry JK (eds): Antiepileptic Drugs, ed 3, New York, Raven Press, 1989, pp 85-102.
30. Turgeon SM, Albin RL: Postnatal ontogeny of GABAb binding in rat brain, Neuroscience 1994:62:601-613.
31. Velisck L, Kubovà H, Polii M, Stankova L, Mares P, Schickerovà R: Pentylenetetrazol-induced seizures in rats: An ontogenetic study, Nau-nvn Schmicdebergs Arch Pharmacol 1992:346:588-591.
32. Polii M, Mares P: Flutiarizine influences Metrazol-induced seizures in developing rats, Epilepsy Res 1987:1:302-305.
33. Holm S: A simple sequentially rejec-tive multiple test procedure, Scand J Stat 1979:6:56-70.
34. Zouhar A, Mares P, Liskovà K, Mudrochova M: Motor and clcctrocor-ticographic epileptic activity induced by bicuculline in developing rats, Epilepsia 1989:30:501-510.
35. Morselli PL: Development of physiological variables important for drug kinetics: in Morselli PL, Pippcnger CE, Pcnry JK (eds): Antiepilcptic Drug Therapy in Pediatrics, New York, Raven Press, 1983, pp 1-12.
36. Pippcnger CE: Maturation of bio-transformation rates; in Morselli PL, Pippcnger CE, Penry JK (eds): Antiepilcptic Drug Therapy in Pediatrics, New York, Raven Press, 1983, pp 333-338.
37. Goodman Gilman A, Rail TW, Nies AS, Taylor P (eds): Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, Per-gamon Press, 1990, pp 479-480.
38. Dutar P, Nicoli RA: Pre- and post-synaptic GABAb receptors in the hippocampus have different pharmacological properties, Neuron 1988:1:585-591.
39. b-mediated activity in the rat dentate gvrus, Brain Res Dev Brain Res 1994:77:295-298.
40. Fukuda A, Modv I, Prince DA: Differential ontogenesis of presynaptic and postsynaptic GABAb inhibition in rat somatosensory cortex, J Neurophysiol 1993:70:448-452.
41. Brady RJ, Swann JW: Postsynaptic actions of baclofen associated with its antagonism of bicucullinc-in-duccd epileptogcnesis in hippocampus, Cell Mol Neurobiol 1984:4: 403-408.